Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06367959 · ClinicalTrials.gov registry record · NA

Health Benefits of Writing Therapy Among Asian American Cancer Survivors

A NA study of Cancer, sponsored by M.D. Anderson Cancer Center.

Recruiting
Registry status
NA
Development phase
192
Enrollment target
1
Study location

NCT06367959: Recruiting NA study of Cancer, sponsored by M.D. Anderson Cancer Center.

NCT06367959 is a NA study of Cancer that is actively recruiting participants, run by M.D. Anderson Cancer Center. The registered enrollment target is 192 participants, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT06367959, a NA study of Cancer, is actively recruiting participants, sponsored by M.D. Anderson Cancer Center.

RECRUITING
Registry status
NA
Development phase
192 participants
Enrollment target
1
Study location

Study Summary

To learn more about participant experience as a Asian American immigrant breast cancer survivor and how writing about participant experiences may affect participant's health.

Conditions Studied

Interventions

  • BEHAVIORAL Questionnaires
  • BEHAVIORAL Esays

Study Locations (1)

Texas

  • MD Anderson Cancer Center - Houston

Trial Details

FieldValue
Enrollment Target 192 participants
Start Date 2023-07-27
Est. Completion 2026-08-31
Phase NA
M.D. Anderson Cancer Center

2,692 total trials

What NCT06367959 shows while recruiting

NCT06367959 is an interventional study that assigns participants to a tested intervention. The registered 192 participants enrollment target is mid-sized for trials with a published cap, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (95% lower).

The record links to 1 condition, with Cancer appearing as the primary indexed condition, and to 2 interventions - of which Questionnaires is the first listed.

NCT06367959 reports a single indexed study location in Texas.

Frequently Asked Questions

What is clinical trial NCT06367959 about?

NCT06367959 is a clinical study titled "Health Benefits of Writing Therapy Among Asian American Cancer Survivors". To learn more about participant experience as a Asian American immigrant breast cancer survivor and how writing about participant experiences may affect participant's health.

What is the current status of trial NCT06367959?

This trial is currently recruiting. It is a NA study. The enrollment target is 192 participants. The study started on 2023-07-27. Estimated completion is 2026-08-31.

What conditions does trial NCT06367959 study?

This clinical trial studies the following conditions: Cancer.

What interventions are being tested in trial NCT06367959?

The interventions under investigation include: Questionnaires (BEHAVIORAL), Esays (BEHAVIORAL).

Who is sponsoring clinical trial NCT06367959?

This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06367959 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06367959's enrollment target sits among peer trials

192 239th of 615 higher than 376 of 615 other Cancer trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01492972 · 192 participants · Phase 3

    Hypo-fractionated Radiation Therapy With or Without Androgen Suppression for Intermediate Risk Prostate Cancer

  • NCT01973881 · 192 participants

    Quantitative MRI for Myelofibrosis

  • NCT02535702 · 192 participants · NA

    Development Of Neuroimaging Methods To Assess The Neurobiology Of Addiction

  • NCT03622359 · 192 participants · NA

    Radiotracer-Based Perfusion Imaging of Patients With Peripheral Arterial Disease

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06367959, the US trial registry maintained by the National Library of Medicine. NCT06367959 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.